2004 (9) TMI 439

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... h, SDR, for the Respondent. [Order per : C. Satapathy, Member (T)]. - Heard both sides at length. The appellants manufacture several P or P medicines such as Ocupol, Ocupol-D, Cipro-Cent etc. In addition to using these names of medicines, they also use 'centaur' on the packings. It is the claim of the appellants that 'centaur' is only a house-mark and not a brand name. They also claim that the .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... daya Chandra Suvarna - 2002 (150) E.L.T. 1050 (Tri. - Del.) (8) Voltarc India Pvt. Ltd. & Anr. v. C.C.E., Guntur & Vice Versa - 2004 (172) E.L.T. 221 (Tribunal) = 2004 (63) RLT 58 (CESTAT-Ban.) (9) C.C.E., Hyderabad v. Sanghi Threads - 2004 (171) E.L.T. 112 (Tribunal) = 2004 (62) RLT 991 (CESTAT- Ban.) (10) Sri Rama Engineers v. C.C.E., Bangalore - 2002 (150) E.L.T. 1008 (Tri.-Chennai) (11) Av .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... marketed under different brand names whereas 'centaur' is marked on all the medicines. As such, following the Apex Court decision in Astra (supra), we hold 'centaur' to be a house mark only which does not establish a relationship between the mark and the medicines. We also note that the definitions of 'brand name' and 'trade mark' are similar for classifying P or P medicines and under the small-s .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X